Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targretin with or without phototherapy in Japanese patients with cutaneous T-cell lymphoma (C-Little)
jRCTs041180094Completed
- Sponsor
- Minophagen Pharmaceutical Co., Ltd.
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of bexarotene in cutaneous T-cell lymphoma (CTCL) (2 arms), sponsored by Minophagen Pharmaceutical Co., Ltd. Primary endpoints: Modified Severity-weighted Assessment Tool (mSWAT) and Physician's Global Assessment (PGA). Started Apr 2019; status: completed.
02
Drugs
bexarotene
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on jRCTs041180094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180094.